Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Long Term Incentive Plan

5 Jun 2015 07:30

RNS Number : 3052P
Allied Minds PLC
05 June 2015
 



 

 

FOR RELEASE ON 05 JUNE 2015

 

Allied Minds plc (the "Company" or the "Group")

 

Long Term Incentive Plan

 

Allied Minds plc, an innovative U.S.-focused science and technology development and commercialisation company, announces that on 04 June 2015 it made conditional awards of 450,251 ordinary shares of one pence each ("Ordinary Shares") to certain directors, other persons discharging managerial responsibilities ("PDMRs") and certain other employees under its Long Term Incentive Plan (the "LTIP").

 

Conditional awards in the form of restricted share units have been made to the directors and PDMRs totalling 302,930 Ordinary Shares as follows:

 

Director/PDMR

Maximum number of Ordinary Shares conditionally awarded in respect of 2015 LTIP

Maximum number of conditionally awarded Ordinary Shares outstanding at the date of this announcement (including 2015 LTIP)

Chris Silva

126,630

1,524,971

Marc Eichenberger

65,357

904,362

Michael Turner

61,273

900,278

Omar Amirana

16,339

320,246

Svetoslav Milenkov

8,823

241,880

Peter Dolan (Non-Executive)

8,170

8,170

Richard Davis (Non-Executive)

5,446

5,446

Kevin Sharer (Non-Executive)

5,446

5,446

Jeffrey Rohr (Non-Executive)

5,446

5,446

 

The number of Ordinary Shares stated is the maximum number that could be issued to each director or PDMR upon full satisfaction of the performance conditions attaching to the awards. The awards granted to the non-executive directors are not subject to performance conditions, but instead vest in three equal tranches on the first, second and third anniversaries of grant, subject to the non-executive director continuing to provide services to the Group on the relevant vesting date.

 

In addition to the above, awards in the form of restricted share units over a total of 147,321 Ordinary Shares were made to certain other of the Group's employees pursuant to the 2015 LTIP.

 

The performance conditions attaching to the 2015 awards (other than the non-executive director awards) are based on the achievement of performance metrics measured as follows: 60% of each award will be subject to performance conditions based on the Company's total shareholder return (TSR) performance in respect of the period from 01 January 2015 through 31 December 2017; and 40% of each award will be subject to performance conditions based on a basket of shareholder value metrics (assessed on a scorecard basis over the three year period to 31 December 2017), including but not limited to: (i) the increase in quality of pipeline intellectual property reviewed; (ii) the increase in quality of the partnership pipeline; and (iii) subsidiary level performance (assessed by reference to such matters as external funding raised, corporate collaborations, product co-development and proof of principal commercial pilots and revenues), as further described in the Directors' Remuneration Report of the 2014 Annual Report and Accounts. The Group's Remuneration Policy and Annual Remuneration Report were recently approved by the Company's shareholders at its Annual General Meeting held on 28 May 2015.

 

The awards will vest, to the extent that the performance conditions have been satisfied, on the date following 31 December 2017 on which the extent to which the performance conditions have been satisfied is determined, and the Ordinary Shares will be issued as soon as practicable after such date.

 

As at the date of this announcement, a total of 5,048,700 Ordinary Shares have been conditionally awarded to directors, PDMRs and employees of the Company pursuant to the LTIP and remain subject to performance conditions (other than the non-executive director awards). The Company currently has 214,490,579 Ordinary Shares in issue.

 

About Allied Minds

 

Allied Minds (LSE: ALM) is an innovative U.S. science and technology development and commercialization company. Operating since 2006, Allied Minds forms, funds, manages and builds products and businesses based on innovative technologies developed at leading U.S. universities and federal research institutions. Allied Minds serves as a diversified holding company that supports its businesses and product development with capital, central management and shared services. More information about the Boston-based company can be found at www.alliedminds.com.

 

For more information, please contact:

Allied Minds plc www.alliedminds.com

Peter Dolan, Non-Executive Chairman +1 617 419 1800

Chris Silva, Chief Executive Officer +1 617 419 1800

FTI Consulting

Ben Atwell, Matthew Cole +44 (0) 20 3727 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBRGDLDGGBGUS
Date   Source Headline
15th Oct 20193:54 pmRNSHolding(s) in Company
26th Sep 20197:00 amRNSHalf-year Report
24th Sep 20197:00 amRNSProposed sale of interest in HawkEye360 for $65.6m
17th Sep 20197:00 amRNSFCC approves initial commercial deployment of CBRS
16th Sep 20194:40 pmRNSSecond Price Monitoring Extn
16th Sep 20194:35 pmRNSPrice Monitoring Extension
10th Sep 201912:45 pmRNSFederated positioned to commercialise services
4th Sep 20197:00 amRNSFederated Wireless raises $51m in Series C round
27th Aug 20193:47 pmRNSNotice of Results
20th Aug 20192:53 pmRNSHolding(s) in Company
16th Aug 20195:32 pmRNSHolding(s) in Company
6th Aug 20197:00 amRNSHawkEye 360 raises $70 million Series B Financing
2nd Aug 20194:38 pmRNSHolding(s) in Company
1st Aug 20197:00 amRNSTotal Voting Rights
9th Jul 201910:50 amRNSHolding(s) in Company
2nd Jul 20195:09 pmRNSDirector/PDMR Shareholding
2nd Jul 20195:08 pmRNSDirector/PDMR Shareholding
2nd Jul 20194:59 pmRNSDirector/PDMR Shareholding
2nd Jul 20194:53 pmRNSDirector/PDMR Shareholding
2nd Jul 20194:52 pmRNSDirector/PDMR Shareholding
2nd Jul 201911:02 amRNSHolding(s) in Company
28th Jun 20195:49 pmRNSResults of Annual General Meeting
28th Jun 20197:00 amRNSAnnual General Meeting Statement
20th Jun 20197:00 amRNSDirectorate Change
10th Jun 20194:29 pmRNSCorrection: Holding(s) in Company
10th Jun 20191:18 pmRNSHolding(s) in Company
10th Jun 20197:00 amRNSDirectorate Change and Business Update
7th Jun 201912:41 pmRNSHolding(s) in Company
28th May 20193:03 pmRNSHolding(s) in Company
16th May 20194:45 pmRNSHolding(s) in Company
16th May 20199:56 amRNSHolding(s) in Company
9th May 20199:17 amRNSBlock Listing Six-Monthly Return
9th May 20199:17 amRNSBlock Listing Six-Monthly Return
3rd May 20194:25 pmRNSNotice of AGM
30th Apr 20194:25 pmRNSNotice of Annual Report
26th Apr 20197:00 amRNSAnnual Financial Report
24th Apr 20197:00 amRNSNotice of Full-Year Results
10th Apr 20194:35 pmRNSPrice Monitoring Extension
5th Apr 20194:40 pmRNSSecond Price Monitoring Extn
5th Apr 20194:35 pmRNSPrice Monitoring Extension
29th Mar 20191:02 pmRNSHolding(s) in Company
4th Mar 20194:28 pmRNSHolding(s) in Company
1st Mar 201911:13 amRNSTotal Voting Rights
27th Feb 20191:49 pmRNSDirector/PDMR Shareholding
26th Feb 20197:00 amRNSHawkEye 360 commissions satellite cluster
22nd Feb 201911:25 amRNSDirector/PDMR Shareholding
7th Feb 20197:00 amRNSTrading Statement
12th Dec 201812:07 pmRNSSecond Price Monitoring Extn
12th Dec 201812:02 pmRNSPrice Monitoring Extension
7th Dec 201812:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.